Notable Mergers and Acquisitions of the Day 8/13 (CVS/LDG, DNA, HRB/AMP)
More News related to AMP
- Notice To Securities America, CapWest Securities and Cullum & Burks Securities Customers Who Purchased Medical Capital Notes
- Ameriprise Financial and its Employees and Advisors Pledge More Than $4.4 Million to Nonprofit Organizations
- Beacon's Fixed Annuity Premium Study Reports Third Quarter's Fixed Annuity Sales
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Noteholder Notice: Zwerling, Schachter & Zwerling, LLP and Kohrman Jackson & Krantz, PLL Alert Purchasers of Medical Capital Notes of November 20, 2009 Deadline for Filing a Motion Seeking to
More News related to CVS
- The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against CVS Caremark Corporation
- Humana and CVS Caremark's MinuteClinic Expand Member Access to Convenient Quality Care
- MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast
- Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in CVS Caremark Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsui
- CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital
More News related to DNA
- Piper Jaffray Reiterates an 'Overweight' on Regeneron Pharmaceuticals (REGN); Raises Price Target
- Biogen Idec (BIIB) Announces Decision By Arbitration Panel in Issues with Genentech (DNA)
- Genentech (DNA) Announces Voluntary Withdrawal of Raptiva from the U.S. Market
- FDA ODA Committee Recommends Accelerated Approval of Genentech's (DNA) Avastin for Brain Cancer
- Genentech (DNA) said FDA committee unamiously recommends accelerated approval of Avastin in brain cancer
More News related to Special Reports
- Top 10 News Items 11/30-12/04: Non-Farm Payrolls Much Better-Than-Expected, Comcast to Take 51% Stake in NBC Universal, BofA to Repay $45B in TARP Funds
- Trading Radar for 12/7: Kroger (KR), Pep Boys (PBY), Krispy Kreme (KKD), Casey's General Stores (CASY) Report
- Unusual 11 Mid-Day Movers 12/04: BIG, FLOW, SNV, OCLS Higher; TTWO, ZIOP, VSNT, SWHC Lower
- Notable ETF Movers 12/04: UUP, UNG Up; XME, GDX, GLD, SLV Down
- Notable Analyst Rating Changes 12/04: BAC, SNV, FSLR, AKAM Upgraded; TTWO, SWHC, AKS, NFLX Downgraded
StreetInsider.com Notable Mergers and Acquisitions of the Day:
- CVS Caremark Corporation (NYSE: CVS) and Longs Drug Stores Corporation (NYSE: LDG) entered into a definitive agreement under which CVS Caremark will acquire Longs for $71.50 per share in cash for a total purchase price of $2.9 billion including the assumption of net debt.
- Genentech's (NYSE: DNA) special committee responded to Roche's proposal to acquire the company for $89, saying it "substantially undervalues the company."
The special committee does not support the proposal, but said they would consider a proposal at a higher price.
- H&R Block (NYSE: HRB) signed a definitive agreement to sell H&R Block Financial Advisors to Ameriprise Financial, Inc. (NYSE: AMP) The transaction is subject to customary regulatory approvals, and is expected to close in four to six months.
The purchase price is $315 million in cash, and is subject to various adjustments at closing based on changes in the balance sheet and advisor retention. Current book value for HRBFA is slightly less than $300 million. Depending on final adjustments, the transaction is not expected to result in a material gain or loss, although it will generate cash proceeds (including repayment of inter-company liabilities) of approximately $340 million. The transaction will also monetize approximately $175 million of goodwill currently on H&R Block's books.
Related Categories
Special ReportsStocks Mentioned
+0.17
-0.04Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
